Status:
COMPLETED
A Randomized Control Trial of a Digital Health Tool
Lead Sponsor:
Kaiser Permanente
Conditions:
Suicide and Self-harm
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This randomized trial evaluated whether sending population-based invitation messages through the electronic health record to visit Lock to Live (L2L), a web-based decision aid that incorporates patien...
Detailed Description
Lock to Live (L2L) is a web-based decision aid that incorporates patients' values into recommendations for safe storage of firearms and medications. This randomized trial evaluated whether sending pop...
Eligibility Criteria
Inclusion
- aged 18 years or older (\>18 yrs.)
- suicide risk based on validated risk algorithm (patients falling within the 75th- 99th risk percentile based on the suicide risk algorithm)
- Patients with a recent visit within Mental Health department or within Primary Care department w. Mental Health diagnosis (recent defined as within the prior month from the date of the algorithm run date)
- English noted as primary language, or patient flag for interpreter needed is not set
- Patient is not deceased
- Patient is registered on kp.org to receive online message
Exclusion
- A recorded diagnosis of: Dementia/ or other cognitive impairment (including developmental delay), Psychosis, Schizophrenia, Autism Spectrum Disorder
- Non-English speaker
- Receiving home-based palliative care, or hospice care
- In a skilled nursing facility
- On the Research Exclusion list - Do Not Contact
- Patient has flag for health proxy
Key Trial Info
Start Date :
April 19 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2022
Estimated Enrollment :
20131 Patients enrolled
Trial Details
Trial ID
NCT05288517
Start Date
April 19 2021
End Date
March 1 2022
Last Update
April 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaiser Permanente Colorado, Institute for Health Research
Aurora, Colorado, United States, 80014